PRODUCTS

..............................................................

PRE-QUALIFIED HUMAN CELLS

PURE CARDIOMYOCYTES

.

LABORATORY SERVICES

..............................................................

CONTRACT ASSAY SERVICES

CONTRACT RESEARCH

ASSAY DESIGN & DEVELOPMENT

OPTIONAL ON-SITE SERVICES

.

EDUCATIONAL SERVICES

..............................................................

SUMMARY OF EDUCATIONAL SERVICES

.

CONSULTING

..............................................................

SUMMARY OF CONSULTING SERVICES

..............................................................

 

What's New

 

ReachBio is now the exclusive North American distributor for Axiogenesis AG.  Initial products consist of Cor.AT® pure cardiomyocytes for drug development, cardiotoxicity, hypertrophy and electrophysiology applications.

 

:: more info

 

..............................

 

CONFERENCES

 

Society of Toxicology (SOT), Booth and Exhibitor Hosted Seminar

 

Molecular Medicine Tri Conference Booth Exhibit

 

 

 

 

Home > Contract Assay > Analysis of Clinical Samples

 

Analysis of Clinical Samples

 

ReachBio specializes in providing value added assay services in support of ongoing clinical trials. We can accept multiple samples from single institutions or multiple centers for analysis. Our West Coast location facilitates receipt of your valuable clinical samples via overnight delivery from all parts of Continental North America. We understand the precious value of these samples and deal with each of them with the utmost care to ensure that high quality informative data will be generated from them.

 

ReachBio can perform the following assay services with clinical samples:

 

  • Blood cell counts

  • Colony Forming Cell (CFC) content per ml of blood

  • Flow cytometric analysis of specific cell populations

  • Comparison of parameters between normal and diseased individuals

  • Quantification of progenitor content in cord blood samples

Note: ReachBio offers a related service to the one described above that involves performing progenitor assays (i.e. CFC assays) using disease-specific cells provided by us. For those interested in that service, please click here.

 

 

 

 © ReachBio LLC    All Rights Reserved

 

1 206 420 0300  |